Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors (original) (raw)

• Bonnet D, Dick JE . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730–736.
  Article CAS PubMed Google Scholar
• Ailles LE, Gerhard B, Kawagoe H, Hogge DE . Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood 1999; 94: 1761–1772.
  CAS PubMed Google Scholar
• Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ . Lack of expression of Thy-1 (CD90) on acute myeloid leukaemia cells with long-term proliferative ability in vitro and in vivo. Blood 1997; 89: 3104–3112.
  CAS PubMed Google Scholar
• Blair A, Hogge DE, Sutherland HJ . Most acute myeloid leukaemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34+/CD71−/HLA-DR−. Blood 1998; 92: 4325–4335.
  CAS PubMed Google Scholar
• Blair A, Sutherland HJ . Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit. Exp Hematol 2000; 28: 660–671.
  Article CAS PubMed Google Scholar
• Feuring-Buske M, Hogge DE . Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38− progenitor cells from patients with acute myeloid leukemia. Blood 2001; 97: 3882–3889.
  Article CAS PubMed Google Scholar
• Bonnet D, Bhatia M, Wang JCY, Kapp U, Dick JE . Cytokine treatment of accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant 1999; 23: 203–209.
  Article CAS PubMed Google Scholar
• Terpstra W, Leenen PJ, van den BC, Prins A, Loenen WA, Verstegen MM et al. Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2MDP liposomes. Leukemia 1997; 11: 1049–1054.
  Article CAS PubMed Google Scholar
• Rombouts WJ, Martens AC, Ploemacher RE . Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model. Leukemia 2000; 14: 889–897.
  Article CAS PubMed Google Scholar
• Ailles LE, Gerhard B, Hogge DE . Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood 1997; 90: 2555–2564.
  CAS PubMed Google Scholar
• Hogge DE, Ailles LE, Gerhard B . Cytokine responsiveness of primitive progenitors in acute myelogenous leukemia. Leukemia 1997; 11: 2220–2221.
  CAS PubMed Google Scholar
• Sutherland HJ, Blair A, Zapf RW . Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood 1996; 87: 4754–4761.
  CAS PubMed Google Scholar
• Christianson SW, Greiner DL, Hesselton R, Leif JH, Wagar EJ, Schweitzer IB et al. Enhanced human CD4+ T cell engraftment in _β_2-microglobulin-deficient NOD-scid mice. J Immunol 1997; 158: 3578–3586.
  CAS PubMed Google Scholar
• Kollet O, Peled A, Byk T, Ben-Hur H, Greiner D, Shultz L et al. β_2 microglobulin-deficient (B2m_null) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000; 95: 3102–3105.
  CAS PubMed Google Scholar
• Glimm H, Eisterer W, Lee K, Cashman J, Holyoake TL, Nicolini F et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-_β_2 microglobulin-null mice. J Clin Invest 2001; 107: 199–206.
  Article CAS PubMed PubMed Central Google Scholar
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group. Ann Intern Med 1985; 103: 620–625.
  Article CAS PubMed Google Scholar
• Hogge DE, Lansdorp PM, Reid D, Gerhard B, Eaves CJ . Enhanced detection, maintenance and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human Steel factor, interleukin-3 and granulocyte colony-stimulating factor. Blood 1996; 88: 3765–3773.
  CAS PubMed Google Scholar
• Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180–191.
  CAS PubMed Google Scholar
• Nicolini FE, Cashman JD, Humphries RK, Eaves CJ . Transplantation of human marrow in NOD/SCID mice genetically engineered to continuously produce human IL-3, GM-CSF and Steel Factor (SF) results in increased numbers of human progenitors in the circulation without compromising overall engraftment. Blood 2000; 96: 292a (Abstract).
  Google Scholar
• Feuring-Buske M, Frankel A, Gerhard B, Hogge D . Variable cytotoxicity of diphtheria toxin 388-granulocyte–macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells. Exp Hematol 2000; 28: 1390–1400.
  Article CAS PubMed Google Scholar
• Cashman JD, Eaves CJ . High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. Blood 2000; 96: 3979–3981.
  CAS PubMed Google Scholar
• Guan Y, Ralph S, Hogge DE . Polyclonal normal hematopoietic progenitors in patients with acute myeloid leukemia. Exp Hematol 2002; 30: 721–728.
  Article CAS PubMed Google Scholar
• Feuring-Buske M, Frankel AE, Alexander RL, Gerhard B, Hogge DE . A diphtheria toxin–interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors. Cancer Res 2002; 62: 1730–1736.
  CAS PubMed Google Scholar